HQL Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 21:51):

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe...

Stats
Dagens volum	52 823.00
Gjennomsnittsvolum	104 361
Markedsverdi	358.14M
Neste inntjeningsdato	( $0 ) 2024-06-03
Last Dividend	$0.300 ( 2023-11-21 )
Next Dividend	$0 ( N/A )
P/E	16.58
ATR14	$0.0130 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-25	Saba Capital Management, L.p.	Buy	97 574	Common Stock
2024-04-24	Saba Capital Management, L.p.	Buy	20 529	Common Stock
2024-04-23	Saba Capital Management, L.p.	Buy	48 203	Common Stock
2024-04-22	Saba Capital Management, L.p.	Buy	2 022	Common Stock
2024-04-19	Saba Capital Management, L.p.	Buy	42 459	Common Stock

INSIDER POWER
100.00
Last 56 transactions
Buy: 417 546 \| Sell: 55 759

Volum Korrelasjon

Lang: -0.13 (neutral)

Kort: 0.00 (neutral)

Signal:(39.664) Neutral

Tekla Life Sciences Korrelasjon

10 Mest positive korrelasjoner
FPI	0.888
TSN	0.883
ASH	0.878
DHX	0.878
AMRC	0.874
DVN	0.873
CWT	0.871
PDS	0.868
CVX	0.867
EBR-B	0.864

10 Mest negative korrelasjoner
VCRA	-0.862
AMAM	-0.861
COR	-0.86
SCX	-0.856
IOT	-0.853
NGL	-0.845
FPAC-UN	-0.845
MOG-B	-0.842
TNK	-0.835
TK	-0.831

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Tekla Life Sciences Korrelasjon - Valuta/Råvare

0.40
( neutral )

0.70
( moderate )

0.00
( neutral )

0.79
( moderate )

0.23
( neutral )

-0.78
( moderate negative )

Tekla Life Sciences Økonomi

Annual	2023
Omsetning:	$23.52M
Bruttogevinst:	$18.28M (77.71 %)
EPS:	$0.830

FY	2023
Omsetning:	$23.52M
Bruttogevinst:	$18.28M (77.71 %)
EPS:	$0.830

FY	2022
Omsetning:	$-103.25M
Bruttogevinst:	$-108.80M (105.37 %)
EPS:	$-4.07

FY	2021
Omsetning:	$65.69M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$2.78

Financial Reports:

No articles found.

Tekla Life Sciences Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.310 (N/A)	$0.310 (N/A)	$0.330 (N/A)	$0.320 (N/A)	$0.320 (N/A)	$0.300 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Tekla Life Sciences Dividend Information - Dividend King

Dividend Sustainability Score: 1.232 - low (50.00%) | Divividend Growth Potential Score: 1.008 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$1.640	1996-11-14
Last Dividend	$0.300	2023-11-21
Next Dividend	$0	N/A
Payout Date	2024-01-10
Next Payout Date	N/A
# dividends	99	--
Total Paid Out	$43.17	--
Avg. Dividend % Per Year	5.54%	--
Score	5.04	--
Div. Sustainability Score	1.232
Div.Growth Potential Score	1.008
Div. Directional Score	1.120	--

Next Divdend (Est)
(2024-05-06)

$0.326 Estimate 38.53 %

Dividend Stability

0.77 Good

Dividend Score

5.04

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1996	$1.640	10.80%
1997	$0.740	5.38%
1998	$0.360	2.76%
1999	$1.110	9.06%
2000	$4.16	20.50%
2001	$3.14	14.90%
2002	$2.18	10.20%
2003	$1.240	10.10%
2004	$1.365	8.62%
2005	$2.06	13.00%
2006	$1.240	7.90%
2007	$1.170	8.74%
2008	$1.100	8.33%
2009	$0.420	4.59%
2010	$0.520	5.46%
2011	$1.010	9.29%
2012	$1.160	10.00%
2013	$1.390	9.19%
2014	$1.770	8.72%
2015	$2.80	11.20%
2016	$2.07	8.99%
2017	$1.620	9.38%
2018	$1.620	8.18%
2019	$1.400	9.03%
2020	$1.560	8.98%
2021	$1.690	8.71%
2022	$1.360	7.05%
2023	$1.270	8.87%
2024	$0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
ZTR	Dividend King	2024-02-09	Monthly	37	8.35%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.568	1.500	10.00	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0556	1.200	8.15	9.78	[0 - 0.3]
returnOnEquityTTM	0.0813	1.500	-0.207	-0.311	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.0000000	2.00	0.0000000	0.0000000	[0 - 30]
freeCashFlowPerShareTTM	0.0000000	2.00	0.0000000	0.0000000	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.867	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.568	1.000	0.649	0.649	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.0978	0.800	-2.68	-2.14	[0.5 - 2]
Total Score				1.232

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	15.53	1.000	8.53	0	[1 - 100]
returnOnEquityTTM	0.0813	2.50	-0.133	-0.311	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0000000	2.00	0.0000000	0.0000000	[0 - 30]
dividendYielPercentageTTM	10.25	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0000000	2.00	0.0000000	0.0000000	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0614	1.500	-3.74	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0000000	1.000	-2.50	0	[0.1 - 0.5]
Total Score				1.008

Tekla Life Sciences

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.